ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Saturday, November 7, 2020

9:00AM-11:00AM: Abstract Number: 0750

Nuclei Detection in Rheumatoid Arthritis Synovial Tissue Using Artificial Intelligence

RA – Diagnosis, Manifestations, & Outcomes Poster II: Biomarkers

9:00AM-11:00AM: Abstract Number: 0653

Nutrient Content of Gout Flare Trigger Foods

Metabolic & Crystal Arthropathies Poster

9:00AM-11:00AM: Abstract Number: 0718

Obesity Impairs Achievement of Clinical Inactive Disease (CID) in Patients with Juvenile Idiopathic Arthritis (JIA) Treated with TNF Inhibitors

Pediatric Rheumatology – Clinical Poster II: JIA

9:00AM-11:00AM: Abstract Number: 0833

Optimized Treatment of Biological Disease Modifying Drugs in Routine Clinical Practice: Survival Study and Analysis of Patient Characteristics

RA – Treatments Poster II: Comparative Effectiveness, Biosimilars, Adherence & the Real World

9:00AM-11:00AM: Abstract Number: 0931

Oropharyngeal Dysfunction in Patients with Systemic Sclerosis – Results of a Monocentric Clinical Study

Systemic Sclerosis & Related Disorders – Clinical Poster II

9:00AM-11:00AM: Abstract Number: 0668

Outcomes and Resource Utilization After Total Knee Arthroplasty in Calcium Pyrophosphate Crystal Deposition Disease Patients: Insights from the National Inpatient Sample Database

Metabolic & Crystal Arthropathies Poster

9:00AM-11:00AM: Abstract Number: 0735

Paediatric Sarcoidosis: Phenotype of a Retrospective Cohort of Biopsy-proven Patients

Pediatric Rheumatology – Clinical Poster II: JIA

9:00AM-11:00AM: Abstract Number: 0835

Pathogenic Effect of Chronic Stress-induced interleukin-12/23p40 on Neuropsychiatric System in Lupus-prone Mouse

SLE – Animal Models Poster

9:00AM-11:00AM: Abstract Number: 0608

Patient and Parent Perspectives in a Academic Pediatric Rheumatology Transition Clinic

Health Services Research Poster

9:00AM-11:00AM: Abstract Number: 0593

Patient Characteristics and Factors Affecting Decision-Making Regarding Total Knee Replacement by Different Types of Physicians Treating Patients with Knee OA

Health Services Research Poster

9:00AM-11:00AM: Abstract Number: 0678

Patient Characteristics and Patterns of Urate-lowering Treatments in Older Patients with Incident Gout

Metabolic & Crystal Arthropathies Poster

9:00AM-11:00AM: Abstract Number: 0526

Patient-Reported Outcomes in Antiphospholipid Syndrome

Antiphospholipid Syndrome Poster

9:00AM-11:00AM: Abstract Number: 0530

Pediatric APS: Clinical Features, Therapeutic Interventions, and Damage in a Series of 22 Cases

Antiphospholipid Syndrome Poster

9:00AM-11:00AM: Abstract Number: 0791

Peficitinib Inhibits Angiogenesis via Suppression of VEGF Production in Rheumatoid Arthritis Fibroblast-like Synoviocytes

RA – Etiology & Pathogenesis Poster

9:00AM-11:00AM: Abstract Number: 0586

Performance Characteristics of ANA by Elisa and Immunofluorescence

Health Services Research Poster

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].